Please login to read the full article.
Scrip Regulatory Affairs
EMA seeks comments on stability data requirements for variations
27 July 2011
Neena Brizmohun
Please login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- Commission consults on extending EU variations regulation to national procedures
- Drug makers have their say on US FDA's proposed biosimilars guidances
- EMA consults on extending guideline on excipients declared in drug labels, packaging
- EMA update on notified body consultations for drug/device borderline products reflects medtech views
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
